These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Report of the conference on the use of stimulant drugs in the treatment of behaviorally disturbed young school children. Psychopharmacol Bull; 1971 Jul; 7(3):23-9. PubMed ID: 5117846 [No Abstract] [Full Text] [Related]
24. Modification of hyperkinetic behavior by nortriptyline. Watter N; Dreifuss FE Va Med Mon (1918); 1973 Feb; 100(2):123-6. PubMed ID: 4683948 [No Abstract] [Full Text] [Related]
26. A clinical study of chloridazepoxide used in psychiatric disorders of children. Kraft IA; Ardali C; Duffy JH; Hart JT; Pearce P Int J Neuropsychiatry; 1965 Oct; 1(5):433-7. PubMed ID: 5858883 [No Abstract] [Full Text] [Related]
27. [Hyperkinetic symptoms in children and adolescents with psychosomatic disorders]. Antropov IuF; Balabanova VA; Baranova VA Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(8):8-15. PubMed ID: 20823823 [TBL] [Abstract][Full Text] [Related]
29. Sensitivity reaction to imipramine. Ryback WS; Jorgensen PA; Jorgensen SE Am J Psychiatry; 1973 Aug; 130(8):940. PubMed ID: 4716700 [No Abstract] [Full Text] [Related]
30. Management of hyperkinetic and handicapped children. Livingston S; Pauli LL JAMA; 1969 Apr; 208(4):694-5. PubMed ID: 4238087 [No Abstract] [Full Text] [Related]
31. Proceedings: The relationship between behavioral and psychological test changes in hyperkinetic children. Gittelman-Klein R; Klein DF Psychopharmacol Bull; 1974 Oct; 10(4):34. PubMed ID: 4431867 [No Abstract] [Full Text] [Related]
32. Problems of diagnosis and the definition of comparable groups: a neglected issue in drug research with children. Fish B Am J Psychiatry; 1969 Jan; 125(7):900-8. PubMed ID: 4885445 [No Abstract] [Full Text] [Related]
33. [Study of clinical and encephalographic action of 1035 MD in child neuropsychiatry. Apropos of 33 cases followed during a year]. Savelli A; Rigal J Rev Neuropsychiatr Infant; 1974 Mar; 22(3):199-205. PubMed ID: 4841032 [No Abstract] [Full Text] [Related]
34. The hyperkinetic child--a forgotten entity, its diagnosis and treatment. Levy S Int J Neuropsychiatry; 1966 Aug; 2(4):330-6. PubMed ID: 5966762 [No Abstract] [Full Text] [Related]
35. [L-acetylcarnitine treatment on fragile X patients hyperactive behaviour]. Calvani M; D'Iddio S; de Gaetano A; Mariotti P; Mosconi L; Pomponi MG; Tabolacci E; Torrioli MG; Vernacotola S; Neri G Rev Neurol; 2001 Oct; 33 Suppl 1():S65-70. PubMed ID: 12447823 [TBL] [Abstract][Full Text] [Related]
36. [Behavior disorders in children. Value of symptomatic treatment by a psycholeptic]. Vialatte J Ann Pediatr (Paris); 1966 Nov; 13(11):2725-7. PubMed ID: 5985453 [No Abstract] [Full Text] [Related]
37. [Use of carbamazepine in children with behavior disorders]. Ruíz Castaño G Prensa Med Mex; 1972; 37(5):215-20. PubMed ID: 5069458 [No Abstract] [Full Text] [Related]
38. [The effect of methylphenidate in children with erethitic syndrome]. Müller P Prax Kinderpsychol Kinderpsychiatr; 1971; 20(2):71-4. PubMed ID: 5555347 [No Abstract] [Full Text] [Related]
39. The possible usefulness of anti-cholinergic drugs in the treatment of the hyperkinetic syndrome in children: Part II. Wray SR; Egbe PC West Indian Med J; 1976 Sep; 25(3):155-7. PubMed ID: 973353 [No Abstract] [Full Text] [Related]
40. [Clinical and statistical evaluation of GABOB in behavior disorders in young children]. Amore F; Cavazzuti GB Minerva Med; 1971 Apr; 62(29):1503-13. PubMed ID: 4936825 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]